Supplementary Data from VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases Article Swipe

View

Thomas L. Ekstrom , Nicholas M. Pathoulas , Amelia M. Huehls , Arun Kanakkanthara , Larry M. Karnitz ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1535-7163.22522543

Supplementary Figures S1-S7, figure legends, and Tables S1 and S2.

Related Topics

Reverse Transcription Polymerase Chain Reaction

Chemotherapy

Concepts

Homologous recombination Histone Cisplatin Lysine Poly ADP ribose polymerase Chemistry Genetics Biology DNA Amino acid Polymerase Chemotherapy

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1535-7163.22522543
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4362488682

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4362488682

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1535-7163.22522543

Digital Object Identifier
Title: Supplementary Data from VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-04-03

Full publication date if available
Authors: Thomas L. Ekstrom, Nicholas M. Pathoulas, Amelia M. Huehls, Arun Kanakkanthara, Larry M. Karnitz

List of authors in order
Landing page: https://doi.org/10.1158/1535-7163.22522543

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1535-7163.22522543

Direct OA link when available
Concepts: Homologous recombination, Histone, Cisplatin, Lysine, Poly ADP ribose polymerase, Chemistry, Genetics, Biology, DNA, Amino acid, Polymerase, Chemotherapy

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4362488682
doi	https://doi.org/10.1158/1535-7163.22522543
ids.doi	https://doi.org/10.1158/1535-7163.22522543
ids.openalex	https://openalex.org/W4362488682
fwci	0.0
type	preprint
title	Supplementary Data from VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11914
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9682000279426575
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	PARP inhibition in cancer therapy
topics[1].id	https://openalex.org/T10123
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.9075000286102295
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1312
topics[1].subfield.display_name	Molecular Biology
topics[1].display_name	DNA Repair Mechanisms
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C102744134
concepts[0].level	3
concepts[0].score	0.7141563892364502
concepts[0].wikidata	https://www.wikidata.org/wiki/Q22280388
concepts[0].display_name	Homologous recombination
concepts[1].id	https://openalex.org/C64927066
concepts[1].level	3
concepts[1].score	0.6165093183517456
concepts[1].wikidata	https://www.wikidata.org/wiki/Q36293
concepts[1].display_name	Histone
concepts[2].id	https://openalex.org/C2778239845
concepts[2].level	3
concepts[2].score	0.5883300304412842
concepts[2].wikidata	https://www.wikidata.org/wiki/Q412415
concepts[2].display_name	Cisplatin
concepts[3].id	https://openalex.org/C2776016237
concepts[3].level	3
concepts[3].score	0.4931292235851288
concepts[3].wikidata	https://www.wikidata.org/wiki/Q178430
concepts[3].display_name	Lysine
concepts[4].id	https://openalex.org/C182979987
concepts[4].level	4
concepts[4].score	0.4177058935165405
concepts[4].wikidata	https://www.wikidata.org/wiki/Q3907241
concepts[4].display_name	Poly ADP ribose polymerase
concepts[5].id	https://openalex.org/C185592680
concepts[5].level	0
concepts[5].score	0.39947962760925293
concepts[5].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[5].display_name	Chemistry
concepts[6].id	https://openalex.org/C54355233
concepts[6].level	1
concepts[6].score	0.3975735902786255
concepts[6].wikidata	https://www.wikidata.org/wiki/Q7162
concepts[6].display_name	Genetics
concepts[7].id	https://openalex.org/C86803240
concepts[7].level	0
concepts[7].score	0.3658137321472168
concepts[7].wikidata	https://www.wikidata.org/wiki/Q420
concepts[7].display_name	Biology
concepts[8].id	https://openalex.org/C552990157
concepts[8].level	2
concepts[8].score	0.182876855134964
concepts[8].wikidata	https://www.wikidata.org/wiki/Q7430
concepts[8].display_name	DNA
concepts[9].id	https://openalex.org/C515207424
concepts[9].level	2
concepts[9].score	0.10688742995262146
concepts[9].wikidata	https://www.wikidata.org/wiki/Q8066
concepts[9].display_name	Amino acid
concepts[10].id	https://openalex.org/C82381507
concepts[10].level	3
concepts[10].score	0.06985071301460266
concepts[10].wikidata	https://www.wikidata.org/wiki/Q416878
concepts[10].display_name	Polymerase
concepts[11].id	https://openalex.org/C2776694085
concepts[11].level	2
concepts[11].score	0.05523225665092468
concepts[11].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[11].display_name	Chemotherapy
keywords[0].id	https://openalex.org/keywords/homologous-recombination
keywords[0].score	0.7141563892364502
keywords[0].display_name	Homologous recombination
keywords[1].id	https://openalex.org/keywords/histone
keywords[1].score	0.6165093183517456
keywords[1].display_name	Histone
keywords[2].id	https://openalex.org/keywords/cisplatin
keywords[2].score	0.5883300304412842
keywords[2].display_name	Cisplatin
keywords[3].id	https://openalex.org/keywords/lysine
keywords[3].score	0.4931292235851288
keywords[3].display_name	Lysine
keywords[4].id	https://openalex.org/keywords/poly-adp-ribose-polymerase
keywords[4].score	0.4177058935165405
keywords[4].display_name	Poly ADP ribose polymerase
keywords[5].id	https://openalex.org/keywords/chemistry
keywords[5].score	0.39947962760925293
keywords[5].display_name	Chemistry
keywords[6].id	https://openalex.org/keywords/genetics
keywords[6].score	0.3975735902786255
keywords[6].display_name	Genetics
keywords[7].id	https://openalex.org/keywords/biology
keywords[7].score	0.3658137321472168
keywords[7].display_name	Biology
keywords[8].id	https://openalex.org/keywords/dna
keywords[8].score	0.182876855134964
keywords[8].display_name	DNA
keywords[9].id	https://openalex.org/keywords/amino-acid
keywords[9].score	0.10688742995262146
keywords[9].display_name	Amino acid
keywords[10].id	https://openalex.org/keywords/polymerase
keywords[10].score	0.06985071301460266
keywords[10].display_name	Polymerase
keywords[11].id	https://openalex.org/keywords/chemotherapy
keywords[11].score	0.05523225665092468
keywords[11].display_name	Chemotherapy
language	en
locations[0].id	doi:10.1158/1535-7163.22522543
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1535-7163.22522543
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5067038520
authorships[0].author.orcid	https://orcid.org/0000-0002-9363-2984
authorships[0].author.display_name	Thomas L. Ekstrom
authorships[0].author_position	first
authorships[0].raw_author_name	Thomas L. Ekstrom
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5042097918
authorships[1].author.orcid	https://orcid.org/0000-0002-6071-0798
authorships[1].author.display_name	Nicholas M. Pathoulas
authorships[1].author_position	middle
authorships[1].raw_author_name	Nicholas M. Pathoulas
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5030736588
authorships[2].author.orcid
authorships[2].author.display_name	Amelia M. Huehls
authorships[2].author_position	middle
authorships[2].raw_author_name	Amelia M. Huehls
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5054120163
authorships[3].author.orcid	https://orcid.org/0000-0001-8444-7683
authorships[3].author.display_name	Arun Kanakkanthara
authorships[3].author_position	middle
authorships[3].raw_author_name	Arun Kanakkanthara
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5048801471
authorships[4].author.orcid
authorships[4].author.display_name	Larry M. Karnitz
authorships[4].author_position	last
authorships[4].raw_author_name	Larry M. Karnitz
authorships[4].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1535-7163.22522543
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Data from VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11914
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9682000279426575
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	PARP inhibition in cancer therapy
related_works	https://openalex.org/W2091461259, https://openalex.org/W2149068418, https://openalex.org/W2406608798, https://openalex.org/W2406596433, https://openalex.org/W2080420195, https://openalex.org/W2066496973, https://openalex.org/W2460036924, https://openalex.org/W2021865845, https://openalex.org/W3120025342, https://openalex.org/W2078222809
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/1535-7163.22522543
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1535-7163.22522543
primary_location.id	doi:10.1158/1535-7163.22522543
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1535-7163.22522543
publication_date	2023-04-03
publication_year	2023
referenced_works_count	0
abstract_inverted_index.S1	7
abstract_inverted_index.and	5, 8
abstract_inverted_index.S1-S7,	2
abstract_inverted_index.Tables	6
abstract_inverted_index.figure	3
abstract_inverted_index.Figures	1
abstract_inverted_index.legends,	4
abstract_inverted_index.S2.</p>	9
abstract_inverted_index.<p>Supplementary	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	5
citation_normalized_percentile.value	0.25037601
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False